BRIDGEWAY CAPITAL MANAGEMENT, LLC - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 29 filers reported holding PROTEON THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$73,000
-29.1%
47,200
-20.0%
0.00%0.0%
Q1 2017$103,000
-8.0%
58,9860.0%0.00%0.0%
Q4 2016$112,000
-79.6%
58,9860.0%0.00%
-87.5%
Q3 2016$550,000
+85.8%
58,986
+60.1%
0.01%
+60.0%
Q2 2016$296,000
+221.7%
36,835
+211.2%
0.01%
+150.0%
Q1 2016$92,000
-50.0%
11,8350.0%0.00%
-33.3%
Q4 2015$184,000
+11.5%
11,8350.0%0.00%0.0%
Q3 2015$165,000
-21.8%
11,8350.0%0.00%
-25.0%
Q2 2015$211,00011,8350.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders